DekaBank Deutsche Girozentrale’s Clovis Oncology, Inc. CLVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-28,000
| Closed | -$124K | – | 1511 |
|
|
2021
Q3 | $124K | Hold |
28,000
| – | – | ﹤0.01% | 1281 |
|
|
2021
Q2 | $160K | Hold |
28,000
| – | – | ﹤0.01% | 1267 |
|
|
2021
Q1 | $187K | Hold |
28,000
| – | – | ﹤0.01% | 1193 |
|
|
2020
Q4 | $123K | Buy |
+28,000
| New | +$142K | ﹤0.01% | 1254 |
|
|
2020
Q1 | – | Sell |
-8,389
| Closed | -$95K | – | 1178 |
|
|
2019
Q4 | $95K | Sell |
8,389
-18,600
| -69% | -$135K | ﹤0.01% | 1048 |
|
|
2019
Q3 | $108K | Sell |
26,989
-18,600
| -41% | -$150K | ﹤0.01% | 906 |
|
|
2019
Q2 | $616K | Buy |
45,589
+21,256
| +87% | +$384K | ﹤0.01% | 887 |
|
|
2019
Q1 | $871K | Buy |
24,333
+3,700
| +18% | +$92.8K | 0.01% | 802 |
|
|
2018
Q4 | $371K | Sell |
20,633
-3,700
| -15% | -$75.6K | ﹤0.01% | 878 |
|
|
2018
Q3 | $871K | Buy |
24,333
+583
| +2% | +$22.6K | 0.01% | 819 |
|
|
2018
Q2 | $1.07M | Hold |
23,750
| – | – | 0.01% | 729 |
|
|
2018
Q1 | $1.26M | Sell |
23,750
-24,050
| -50% | -$1.4M | 0.01% | 663 |
|
|
2017
Q4 | $3.43M | Hold |
47,800
| – | – | 0.03% | 449 |
|
|
2017
Q3 | $3.43M | Buy |
47,800
+15,000
| +46% | +$1.19M | 0.03% | 454 |
|
|
2017
Q2 | $3.02M | Hold |
32,800
| – | – | 0.02% | 469 |
|
|
2017
Q1 | $2.06M | Buy |
32,800
+8,100
| +33% | +$492K | 0.02% | 481 |
|
|
2016
Q4 | $1.1M | Buy |
24,700
+1,900
| +8% | +$66.9K | 0.01% | 524 |
|
|
2016
Q3 | $790K | Hold |
22,800
| – | – | 0.01% | 588 |
|
|
2016
Q2 | $343K | Buy |
22,800
+6,300
| +38% | +$92.1K | ﹤0.01% | 757 |
|
|
2016
Q1 | $317K | Sell |
16,500
-2,900
| -15% | -$61.4K | ﹤0.01% | 745 |
|
|
2015
Q4 | $667K | Buy |
19,400
+200
| +1% | +$12.9K | 0.01% | 633 |
|
|
2015
Q3 | $1.77M | Buy |
19,200
+2,650
| +16% | +$229K | 0.02% | 465 |
|
|
2015
Q2 | $1.45M | Buy |
16,550
+600
| +4% | +$51.4K | 0.02% | 502 |
|
|
2015
Q1 | $1.18M | Sell |
15,950
-2,250
| -12% | -$159K | 0.01% | 544 |
|
|
2014
Q4 | $1M | Sell |
18,200
-1,700
| -9% | -$89.3K | 0.01% | 560 |
|
|
2014
Q3 | $903K | Buy |
19,900
+400
| +2% | +$16.7K | 0.01% | 532 |
|
|
2014
Q2 | $807K | Sell |
19,500
-1,300
| -6% | -$67K | 0.01% | 531 |
|
|
2014
Q1 | $1.44M | Buy |
20,800
+1,450
| +7% | +$106K | 0.02% | 420 |
|
|
2013
Q4 | $1.14M | Buy |
19,350
+2,500
| +15% | +$136K | 0.02% | 411 |
|
|
2013
Q3 | $1.02M | Buy |
16,850
+3,550
| +27% | +$252K | 0.02% | 426 |
|
|
2013
Q2 | $905K | Buy |
+13,300
| New | +$598K | 0.02% | 383 |
|
Other funds holding CLVS
N
PAI
DekaBank Deutsche Girozentrale's CLVS Position: Q4 2021 in Review
DekaBank Deutsche Girozentrale sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 28,000 shares — an estimated $124K sold.
DekaBank Deutsche Girozentrale first reported a position in CLVS in Q2 2013 and held it in 31 quarters. The position peaked at $3.43M in Q4 2017. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.
- DekaBank Deutsche Girozentrale reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
- DekaBank Deutsche Girozentrale sold 28,000 Clovis Oncology, Inc. shares in Q4 2021, an estimated $124K.
- DekaBank Deutsche Girozentrale first reported a position in Clovis Oncology, Inc. in Q2 2013 and held it in 31 quarters.
- DekaBank Deutsche Girozentrale's Clovis Oncology, Inc. position peaked at $3.43M in Q4 2017.
- 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2021, filed 2 Feb 2022.